Cite
Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Exudative Age-Related Macular Degeneration.
MLA
Ghorbanihaghjo, Amir, et al. “Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Exudative Age-Related Macular Degeneration.” Acta Medica Iranica, vol. 52, no. 4, Apr. 2014, pp. 265–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=95883559&authtype=sso&custid=ns315887.
APA
Ghorbanihaghjo, A., Javadzadeh, A., Rashtchizadeh, N., Sorkhabi, R., Khalili, H., & Rahimi-Ardabili, B. (2014). Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Exudative Age-Related Macular Degeneration. Acta Medica Iranica, 52(4), 265–270.
Chicago
Ghorbanihaghjo, Amir, Alireza Javadzadeh, Nadereh Rashtchizadeh, Rana Sorkhabi, Hasan Khalili, and Babak Rahimi-Ardabili. 2014. “Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Exudative Age-Related Macular Degeneration.” Acta Medica Iranica 52 (4): 265–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=95883559&authtype=sso&custid=ns315887.